Paper31420554
Atherosclerosis.
Libby P and 7 others. Nat Rev Dis Primers, 2019. Cited by 2,562 papers, by iCite.
Cite this record
ConductScience Library. Atherosclerosis. Papers, record 31420554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31420554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atherosclerosis | Major topic |
| Drug Therapy | |
| Humans | |
| Hyperlipidemias | |
| Mass Screening | |
| Risk Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 HL080472 | NHLBI NIH HHS | United States | R01HL080472 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07520643 | MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling | Background |
Source ClinicalTrials.gov
Cited by1,832
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,562 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985392 | Selenium Nanoparticles in Atherosclerosis and Non-Alcoholic Fatty Liver Disease: A Comprehensive Review of Therapeutic Mechanisms, Targeted Delivery, and Translational Prospects. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42985392 | PubMed |
| 42983283 | Routine metabolic-adiposity indices and incident cardiometabolic multimorbidity among adults with CKM stages 0-3: a prospective cohort study. | BMC Cardiovasc Disord | 2026 | https://conductscience.org/library/papers/42983283 | PubMed |
| 42978991 | Design, Synthesis, and CETP Inhibitory Evaluation of Novel P-methoxybenzene Sulfonamides Supported by Molecular Modeling. | Iran J Pharm Res | 2026 | https://conductscience.org/library/papers/42978991 | PubMed |
| 42964405 | Circulating Interleukin-36 Alpha, Beta, Gamma, and Interleukin-37 Levels in Patients With Chronic Coronary Syndrome. | Cardiol Res | 2026 | https://conductscience.org/library/papers/42964405 | PubMed |
| 42961710 | Predictive and risk stratification performance of CCTA-derived pericoronary adipose tissue radiomics for major adverse cardiovascular events: retrospective development and prospective validation. | Radiol Med | 2026 | https://conductscience.org/library/papers/42961710 | PubMed |
| 42957434 | PAK4 as a cardiometabolic node: tissue-specific metabolic control, cardiovascular remodeling, and therapeutic trade-offs. | Korean J Physiol Pharmacol | 2026 | https://conductscience.org/library/papers/42957434 | PubMed |
| 42955221 | MUSE-Net: a SegFormer-B2-based multi-expert ensemble for multicenter carotid plaque segmentation in ultrasound images. | Med Biol Eng Comput | 2026 | https://conductscience.org/library/papers/42955221 | PubMed |
| 42948745 | Remodeling macrophage efferocytosis and phenotype via targeted nanoimmunotherapy for atherosclerosis. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42948745 | PubMed |
| 42942436 | PAD as a Marker of Systemic Atherosclerosis: A Comprehensive Review of Residual Risk and Contemporary Strategies for MACE and MALE Reduction. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42942436 | PubMed |
| 42939664 | Modulating the NLRP3/IL-1β Axis in Age-Related Atherosclerosis: Natural Products, Molecular Mechanisms, and Translational Perspectives-A Narrative Review. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939664 | PubMed |
| 42939023 | BMA-Net: A Bilateral Attention Network with Retinal Domain Transfer-Learning for CIMT-Based Cardiovascular Risk Classification from Fundus Images. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42939023 | PubMed |
| 42929811 | SUMOylation as a Stress-Responsive Rheostat in Cardiovascular Disease. | Cells | 2026 | https://conductscience.org/library/papers/42929811 | PubMed |
| 42928775 | Targeting Metabolic Drivers of Cardiovascular Disease: Insights for Therapeutic Innovation. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42928775 | PubMed |
| 42924604 | Inflammatory regulatory mechanisms and targeted therapy of antineutrophil cytoplasmic antibodies in atherosclerosis (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42924604 | PubMed |
| 42923720 | Vascular aging biomarkers: the role of ADMA, SDMA, and inflammation. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42923720 | PubMed |
| 42920854 | Macrophage-directed cardiovascular nanomedicines: Linking pharmaceutical design with cell state, lesion niche, and intracellular function. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42920854 | PubMed |
| 42909371 | Cell-derived biomimetic nanomedicines: Emerging theranostic platforms for precision management of atherosclerosis. | Theranostics | 2026 | https://conductscience.org/library/papers/42909371 | PubMed |
| 42909347 | Targeted molecular CT imaging of atherosclerosis and abdominal aortic aneurysm. | Theranostics | 2026 | https://conductscience.org/library/papers/42909347 | PubMed |
| 42905940 | NSG Mice Lacking Apoe: An Immunodeficient Mouse Model of Atherosclerosis. | FASEB J | 2026 | https://conductscience.org/library/papers/42905940 | PubMed |
| 42903377 | Role of insulin resistance in atherosclerosis: underlying mechanisms and emerging stem cell-based therapeutic strategies. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42903377 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31420554
GET https://conductscience.org/api/papers/v1/31420554/cited_by?page=2